Big news for South Africans struggling with obesity: the core patent on semaglutide — the active ingredient in Ozempic and Wegovy — officially expired in South Africa in March 2026. This is a landmark moment that could dramatically change who can access these game-changing weight loss medications. Here's everything you need to know.
Medical Disclaimer: This article is for informational purposes only. Always consult a registered healthcare professional before starting, stopping, or switching any weight loss medication.
What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist — a class of medication that mimics a natural hormone your gut releases after eating. It works by:
- Suppressing appetite and reducing food cravings
- Slowing stomach emptying so you feel full longer
- Improving blood sugar control
- Promoting significant, sustained weight loss
Under brand names like Ozempic (diabetes dosing) and Wegovy (higher-dose weight loss version), semaglutide has become one of the most talked-about medications in the world. Clinical trials show users losing 10–15% of body weight on average — sometimes more.
Why the Patent Expiry Is Such a Big Deal
Until March 2026, Novo Nordisk held an exclusive patent on semaglutide in South Africa. This monopoly allowed them to set premium prices — putting the medication out of reach for most South Africans.
Branded Ozempic currently costs R2,000–R4,500 per month in South Africa depending on the dose, and is rarely covered by medical aids for weight loss. For working-class and middle-income South Africans, that's simply unaffordable.
With the patent now expired, generic pharmaceutical manufacturers can legally produce and sell semaglutide in South Africa. A landmark 2025 study found that semaglutide could theoretically be manufactured for as little as $3 (around R56) per month — though real-world generic prices will be higher, market competition should still push costs down dramatically over time.
When Will Generics Be Available?
Patent expiry doesn't mean generics appear overnight. Here's the realistic timeline:
- Now (2026): Patent expired — generic manufacturers can begin applying to SAHPRA (South African Health Products Regulatory Authority) for approval
- 2026–2027: SAHPRA review and approval process (typically 18–36 months for new applications)
- 2027–2028: First generic semaglutide products likely to reach South African pharmacies
- 2028+: Increased competition drives prices down significantly
India and China are already manufacturing generic semaglutide for their domestic markets. South African importers may look to these sources, but SAHPRA registration is still required before any product can legally be sold here.
What Will Generic Semaglutide Cost in South Africa?
We don't yet know the exact price, but we can look at patterns from other generic drug markets:
- When metformin went generic, prices dropped by 80–90% within a few years
- Generic versions of GLP-1s in India already sell for a fraction of branded prices
- Analysts expect generic semaglutide to reach R400–R800/month in competitive markets by 2028
That would still be a significant monthly expense for many South Africans, but a massive improvement from current prices.
What Should You Do Right Now?
If you've been hoping to try semaglutide but couldn't afford it, here's how to prepare:
1. Talk to Your Doctor
Your GP or an endocrinologist can assess whether semaglutide is appropriate for you. They can also check if your medical aid covers it for diabetes management (which some aids do cover, even if not for weight loss specifically).
2. Watch for Compounded Semaglutide
Some South African compounding pharmacies already offer semaglutide prepared in-house. This operates in a regulatory grey area — proceed with caution and only through a licensed compounding pharmacy with a valid prescription.
3. Don't Buy Unregistered Products
Beware of online sellers offering "generic Ozempic" — if it isn't SAHPRA-registered, it hasn't been tested for safety or efficacy in South Africa. Counterfeit GLP-1 products have already caused harm in other countries.
4. Focus on Lifestyle in the Meantime
Semaglutide works best when combined with healthy eating and regular exercise. Starting those habits now means you'll get better results if and when you do access the medication. Explore our guides on:
- Intermittent fasting for South Africans
- Low-carb diets in South Africa
- Walking for weight loss
- High-protein diet guide
Will Medical Aid Cover Generic Semaglutide?
This is the million-rand question. Currently, most South African medical aids only cover semaglutide (as Ozempic) for registered diabetics. Obesity as a standalone condition is rarely covered.
However, as prices fall and evidence for weight loss benefits grows, there is pressure on schemes to expand coverage. The Council for Medical Schemes is watching international trends closely. Advocates argue that obesity management should be treated as the medical condition it is, not a lifestyle choice.
Alternatives Available Now
While you wait for generics, here are weight loss medication options currently more accessible in South Africa:
- Saxenda (liraglutide) — Another GLP-1, similar mechanism to semaglutide, available but also expensive
- Mounjaro (tirzepatide) — Newer dual GLP-1/GIP agonist, even more effective but pricier
- Orlistat — Older fat-blocker medication, much cheaper, available over-the-counter
- Hoodia gordonii — Natural South African appetite suppressant, available locally
Bottom Line: The semaglutide patent expiry in South Africa is genuinely exciting news for the millions of South Africans living with obesity. Affordable access is still a few years away, but the direction of travel is clear. Stay informed, talk to your doctor, and focus on building healthy habits in the meantime.